Alexandra Philipsen1, Bernd Hesslinger, Ludger Tebartz van Elst. 1. Universitätsklinikum Freiburg, Abteilung für Psychiatrie und Psychotherapie, Universitätsklinikum Freiburg, Hauptstrasse 5, Freiburg, Germany. alexandra.philipsen@uniklinik-freiburg.de
Abstract
INTRODUCTION: Until the late nineties, attention deficit and hyperactivity disorder (ADHD) was often regarded in Germany as a disorder that fades away in late adolescence. However, it has recently become clear from numerous studies that core symptoms of ADHD persist into adulthood in a substantial subgroup of patients. METHODS: Selective review of relevant literature in Medline, up to September 2007. RESULTS: The prevalence of ADHD in adulthood is estimated at about 2%. Core symptoms include attention deficit in the presence of understimulation, chronic restlessness, impulsivity, disorganized behaviour, and disorders of affect regulation. The extent of psychosocial impairment depends on symptom severity, psychiatric comorbidity (such as addiction or depression), and psychosocial support. As in childhood, ADHD in adulthood is a clinical diagnosis. Genetic factors probably play a key role in primary ADHD. Treatment should include psychotherapy and medical treatment. DISCUSSION: ADHD in adulthood is commoner than for example bipolar disorder or schizophrenia. It may be regarded as a risk factor for the development of other psychiatric conditions. Highly effective treatment is possible not only in childhood but also in adulthood. The problem of off-label use of psychotropic medication in adults limits treatment in adult ADHD.
INTRODUCTION: Until the late nineties, attention deficit and hyperactivity disorder (ADHD) was often regarded in Germany as a disorder that fades away in late adolescence. However, it has recently become clear from numerous studies that core symptoms of ADHD persist into adulthood in a substantial subgroup of patients. METHODS: Selective review of relevant literature in Medline, up to September 2007. RESULTS: The prevalence of ADHD in adulthood is estimated at about 2%. Core symptoms include attention deficit in the presence of understimulation, chronic restlessness, impulsivity, disorganized behaviour, and disorders of affect regulation. The extent of psychosocial impairment depends on symptom severity, psychiatric comorbidity (such as addiction or depression), and psychosocial support. As in childhood, ADHD in adulthood is a clinical diagnosis. Genetic factors probably play a key role in primary ADHD. Treatment should include psychotherapy and medical treatment. DISCUSSION: ADHD in adulthood is commoner than for example bipolar disorder or schizophrenia. It may be regarded as a risk factor for the development of other psychiatric conditions. Highly effective treatment is possible not only in childhood but also in adulthood. The problem of off-label use of psychotropic medication in adults limits treatment in adult ADHD.
Authors: Lenard A Adler; Virginia K Sutton; Rodney J Moore; Anthony P Dietrich; Frederick W Reimherr; R Bart Sangal; Keith E Saylor; Kristina Secnik; Douglas K Kelsey; Albert J Allen Journal: J Clin Psychopharmacol Date: 2006-12 Impact factor: 3.153
Authors: E Perlov; A Philipsen; B Hesslinger; M Buechert; J Ahrendts; B Feige; E Bubl; J Hennig; D Ebert; L Tebartz van Elst Journal: J Psychiatr Res Date: 2007-02-15 Impact factor: 4.791
Authors: Caroline S Stevenson; Stephanie Whitmont; Laurel Bornholt; David Livesey; Richard J Stevenson Journal: Aust N Z J Psychiatry Date: 2002-10 Impact factor: 5.744
Authors: Alexandra Philipsen; Harald Richter; Julia Peters; Barbara Alm; Esther Sobanski; Michael Colla; Mirka Münzebrock; Corinna Scheel; Christian Jacob; Evgeniy Perlov; Ludger Tebartz van Elst; Bernd Hesslinger Journal: J Nerv Ment Dis Date: 2007-12 Impact factor: 2.254
Authors: Dominique Endres; Ludger Tebartz van Elst; Simon J Maier; Bernd Feige; Peter Goll; Simon A Meyer; Swantje Matthies; Katharina Domschke; Thomas Lange; Esther Sobanski; Alexandra Philipsen; Kathrin Nickel; Evgeniy Perlov Journal: Biol Sex Differ Date: 2019-10-29 Impact factor: 5.027